Education
About Us
Working with TipRanks
Follow Us
BioSig Technologies Inc (BSGM)
NASDAQ:BSGM
BSGM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.20 - $2.98
Previous CloseN/A
Volume81.57K
Average Volume (3M)437.25K
Market Cap
$12.79M
Enterprise Value$2.82M
Total Cash (Recent Filing)$1.41M
Total Debt (Recent Filing)$689.00K
Price to Earnings (P/E)―
Beta-0.14
Next Earnings
May 19, 2025EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.45
Shares Outstanding23,040,350
10 Day Avg. Volume345,822
30 Day Avg. Volume437,247
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)240.89
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.22
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit156.78
Enterprise Value/Ebitda-0.17
Forecast
1Y Price Target
$2.75Price Target Upside428.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
BioSig Technologies News
PremiumCompany Announcements
BioSig Technologies Delays Form 10-K Filing
PremiumCompany Announcements
BioSig Technologies Shareholders Support Strategic Proposals
PremiumCompany Announcements
BioSig Technologies Announces Executive Leadership Overhaul
---
Bulls Say, Bears Say
Bulls Say
Acquisition PlansThe intention to acquire the assets of Neuro-Kinesis Corporation, a company advancing medical technology, was announced with hopes to close the deal by early 2025.
Market OpportunityThe potential billion-dollar market for PURE EP presents high rewards for the risks, making an investment in BioSig compelling.
Product DevelopmentThe company has developed the PURE EP system, an FDA-cleared device providing essential diagnostic signals during cardiac catheter ablations.
Bears Say
Compliance UncertaintyThe company regained its NASDAQ listing and has until March 2025 to regain full compliance, which poses uncertainty regarding its market presence.
Operational ChallengesThe company announced a major reorganization, terminating a significant number of employees and reducing business operations due to a lack of capital.
ReorganizationThe company announced a major reorganization, terminating a significant number of employees and substantially reducing business operations due to lack of capital.
---
Ownership Overview
12.75% Insiders
0.02%
Mutual Funds
31.93% Other Institutional Investors
55.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BSGM FAQ
What was BioSig Technologies Inc’s price range in the past 12 months?
BioSig Technologies Inc lowest stock price was $0.20 and its highest was $2.98 in the past 12 months.
What is BioSig Technologies Inc’s market cap?
BioSig Technologies Inc’s market cap is $12.79M.
When is BioSig Technologies Inc’s upcoming earnings report date?
BioSig Technologies Inc’s upcoming earnings report date is May 19, 2025 which is in 45 days.
How were BioSig Technologies Inc’s earnings last quarter?
BioSig Technologies Inc released its earnings results on Aug 08, 2024. The company reported -$0.303 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.203.
Is BioSig Technologies Inc overvalued?
According to Wall Street analysts BioSig Technologies Inc’s price is currently Undervalued.
Does BioSig Technologies Inc pay dividends?
BioSig Technologies Inc does not currently pay dividends.
What is BioSig Technologies Inc’s EPS estimate?
BioSig Technologies Inc’s EPS estimate is -0.18.
How many shares outstanding does BioSig Technologies Inc have?
BioSig Technologies Inc has 23,040,350 shares outstanding.
What happened to BioSig Technologies Inc’s price movement after its last earnings report?
BioSig Technologies Inc reported an EPS of -$0.303 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of BioSig Technologies Inc?
Currently, no hedge funds are holding shares in BSGM
---
Company Description
BioSig Technologies Inc
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
---
BSGM Stock 12 Month Forecast
Average Price Target
$2.75
▲(428.85% Upside)
Technical Analysis
Best Analysts Covering BSGM
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-79.84%
reiterated a buy rating 4 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -79.84% per trade.
---